Related references
Note: Only part of the references are listed.The challenge of developing green tea polyphenols as therapeutic agents
C. Huo et al.
INFLAMMOPHARMACOLOGY (2008)
A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent
Kristin R. Landis-Piwowar et al.
CANCER RESEARCH (2007)
Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1α
Zachary Gerhart-Hines et al.
EMBO JOURNAL (2007)
Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators
Julie St-Pierre et al.
CELL (2006)
Neurological mechanisms of green tea polyphenols in Alzheimer's and Parkinson's diseases
O Weinreb et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2004)
Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α):: Transcriptional coactivator and metabolic regulator
P Puigserver et al.
ENDOCRINE REVIEWS (2003)
Green tea polyphenol (-)-epigallocatechin-3-gallate protects rat PC12 cells from apoptosis induced by serum withdrawal
S Mandel et al.
NEUROTOXICITY RESEARCH (2003)
Role of hydroxyl radical formation in neurotoxicity as revealed by in vivo free radical trapping
T Obata
TOXICOLOGY LETTERS (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
The Parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation - A novel mechanism of toxicity
J Lotharius et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
